Are patients with PBC best served by the current regulatory approval model? - European Medical Journal

Are patients with PBC best served by the current regulatory approval model?

Hepatology

The EMJ Podcast | Bonus Episode

PBC experts Prof Dave Jones and Prof Gideon Hirschfield discuss the newest developments and regulatory challenges in advancing treatment.

Spotify | Apple | Amazon MusicDownload MP3 (33:25 mins)

This podcast was funded by ADVANZ PHARMA. The content of the podcast reflects the opinions of the speakers and does not necessarily reflect the views of ADVANZ PHARMA.

Prescribing information here.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given